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Abstract
Background: Left ventricular global longitudinal strain (GLS) with cardiovascular magnetic resonance (CMR) is an
important prognostic biomarker. Its everyday clinical use is limited due to methodological and postprocessing
diversity among the users and vendors. Standardization of postprocessing approaches may reduce the random
operator-dependent variability, allowing for comparability of measurements despite the systematic vendor-related
differences.
Methods: We investigated the random component of variability in GLS measurements by optimization steps which
incrementally improved observer reproducibility and agreement. Cine images in two-, three- and four-chamber-
views were serially analysed by two independent observers using two different CMR-FT softwares. The disparity of
outcomes after each series was systematically assessed after a number of stepwise adjustments which were shown
to significantly reduce the inter-observer and intervendor bias, resulting standardized postprocessing approach. The
final analysis was performed in 44 subjects (ischaemic heart disease n = 15, non-ischaemic dilated cardiomyopathy,
n = 19, healthy controls, n = 10). All measurements were performed blind to the underlying group allocation and
previous measurements. Inter- and intra-observer variability were tested using Bland-Altman analyses, intra-class
correlation coefficients (ICCs) and coefficients of variation (CVs).
Results: Compared to controls, mean GLS was significantly lower in patients, as well as between the two
subgroups (p < 0.01). These differences were accentuated by standardization procedures, with significant increase in
Cohen’s D and AUCs. The benefit of standardization was also evident through improved CV and ICC agreements
between observers and the two vendors. Initial intra-observer variability CVs for GLS parameters were 7.6 and 4.6%,
inter-observer variability CVs were 11 and 4.7%, for the two vendors, respectively. After standardization, intra- and
interobserver variability CVs were 3.1 and 4.3%, and 5.2 and 4.4%, respectively.
Conclusion: Standardization of GLS postprocessing helps to reduce the random component of variability,
introduced by inconsistencies of and between observers, and also intervendor variability, but not the systematic
inter-vendor bias due to differences in image processing algorithms. Standardization of GLS measurements is an
essential step in ensuring the reliable quantification of myocardial deformation, and implementation of CMR-FT in
clinical routine.
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Background
Global longitudinal strain (GLS) is an important prog-
nostic biomarker in the evaluation of the left ventricular
(LV) function [1–3]. Visual assessment of wall motion
abnormalities is fast but dependent on the experience of
the observer and short of objective quantification [4, 5].
In echocardiography, GLS derived by automated
speckle-tracking has been shown superior in detecting
and quantifying subtle impairment of LV systolic func-
tion [2], as well as to provide higher predictive value for
mortality than LV ejection fraction (LV-EF) in the pres-
ence of regional wall motion abnormalities [1], or iso-
lated GLS reduction in the presence of global (diffuse)
systolic impairment [3].
Feature tracking (FT) by cardiac magnetic resonance
(CMR), or CMR-FT, has conceptual similarities with
speckle tracking, in providing quantitative assessment of
myocardial deformation [6]. Despite the methodological
differences in image acquisition and postprocessing, the
similarity extends to the use of routinely acquired cine
(steady-state free precession, SSFP) images, avoiding the
need for additional dedicated sequences, such as tagging
[7, 8]. Numerous studies reported on validation and
agreement with other deformation techniques (reviewed
elsewhere ([8, 9]), which, in summary, reveal that the
measurements derived by CMR-FT are not easily trans-
ferrable, nor in scale or precision. One of the reasons for
the differences is a number of methodologically different
software solutions, pertaining numerous approaches to
automatic contour-placement and tracking, as well as
underlying algorithms of strain calculation [7]. More-
over, despite high reproducibility GLS in some single
centre studies, there remains a remarkable inter-centre
difference despite the use of same vendor, reflecting an
important source of operator induced, or random vari-
ability [10, 11]. We hypothesized that standardization of
user postprocessing may reduce the random component
of variability. Improved precision of measurements may
support transferability of CMR-FT and allow compar-
ability of intervendor and intercentre results, despite the
systematic differences, owing to the different image pro-
cessing algorithms used by vendors. In this study, we
undertook a systematic analysis and elimination of po-
tential errors to guide the development of standardized
operating procedure for local reads by comparison of
two different vendors.
Methods
Anonymized datasets were sourced from the prospective
longitudinal observational multicentre investigator-led
study [12–14]. Groups of unrelated subjects with either
known ischaemic heart disease (IHD) or non-ischaemic
dilated cardiomyopathy (NIDCM), were composed to
examine the influence of regional wall motion abnormal-
ities (RWMA) and diffuse myocardial impairment on
postprocessing of GLS, respectively. The control group
consists of subjects with normal blood pressure, low-
pretest likelihood of cardiomyopathy, normal LV mass,
volumes, and global systolic function, as well as absence
of myocardial scar on late gadolinium enhancement
(LGE) imaging and no regular medication. Clinical
meta-data, including systolic/diastolic blood pressure
(BP), body mass index (BMI) were recorded. Exclusion
criteria for all subjects were the generally accepted con-
traindications to CMR (implantable non-MR safe de-
vices, cerebral aneurysm clips, cochlear implants).
CMR image analysis and acquisition
The CMR protocol, details of image acquisition and
postprocessing have been reported previously [12–14].
All subjects included in this study underwent a CMR
study using a 3.0 T clinical scanner (Skyra, Siemens).
Step 1: Acquisition/Selection of appropriate series
Step 2: Timing of Systole and Diastole (AVC)
Step 3: Play Cine to determine endocardial boundry points and differentiate 
papillary muscles
Step 4: Assessment of adequacy for strain measurement
Step 5: Perform tracking
Step 6: Evaluation of tracking quality
Step 7: Repeat procedure, until adequate tracking is achieved.
Fig. 1 Steps for CMR-Feature tracking
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Cine images were obtained using a balanced steady-state
free precession (SSFP) sequence in combination with
parallel imaging (SENSitivity Encoding, factor 2) and
retrospective gating during expiratory breath- hold (TE/
TR/flip-angle: 1.7 ms/3.4 ms/60°, spatial resolution 1.8 ×
1.8 × 8 mm, temporal resolution of 25 frames/cycle).
Routine CMR analysis of cardiac volumes, function and
mass was performed using commercially available soft-
ware Medis Suite MR v2.1 (Medis medical imaging sys-
tems, Leiden, The Netherlands) [15] using a stack of
gapless short axis (SAX) cine slices. Left ventricular
endocardial borders were drawn manually at end-
diastole and end-systole. The papillary muscles were
traced and included as part of the LV cavity volume. Left
ventricular end-diastolic (EDV) and end-systolic (ESV)
volumes were determined using Simpson’ s rule. Ejection
fraction (EF) was computed as EDV-ESV/EDV. All volu-
metric indices were normalized to body surface area
(BSA).
Single cine slice long-axis views (LAX, 2-, 3-, and 4
chamber view) were used for GLS analysis using CMR-
FT. Images were analysed off-line using two commer-
cially available software packages: Medis Suite MR v2.1
(Medis medical imaging systems, Leiden, The
Fig. 2 Examples for tracking problems and solutions. a - in this case, boundary points have been placed in the pericardium accidentally. b shows
that there is no movement of the lateral wall boundary points in correlation to the ventricular contraction. c and d: In this case, boundary points
were placed correctly and lateral wall tracking was improved
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Netherlands) and CVI42 Version 5.6.6 (Circle Cardiovas-
cular Imaging Inc., Calgary, Canada). GLS was calculated
as the average of the 3 LAX views and expressed as an
absolute global peak systolic strain.
Optimization and derivation of standardized
postprocessing
All readers involved in this project had extensive previ-
ous experience of 2D speckle tracking by echocardiog-
raphy. After training of vendor recommended
postprocessing approaches (handbooks, website informa-
tion, webinars, training with application specialists), a
series of stepwise adjustments was examined by way of
trial and error; these steps were implemented if shown
to beneficially reduce the intra/inter-observer bias. Sub-
sequently, datasets were analysed separately by two inde-
pendent observers, resulting in three sets per each
software or six outputs for each subject and implemen-
tation series. The readers were blind to their own, each
other’s as well as previous measurements. Intraobserver
measurements were repeated after an interim interval of
4 weeks.
Optimization steps were based on a modified approach
described previously [11], as well as comparative evalu-
ation of both readers’ tracking results (Fig. 1). Common
tracking errors and systematic differences were identi-
fied, and agreements were drawn and tested to support a
reproducible approach for assessing GLS. Vendor-
specific approaches to contour-manipulation were ne-
cessary. Using CVI-42, the epicardial and endocardial
contours were manually delineated in all analysed sec-
tions with initial contours set at end diastole. The epi-
cardial contours were purposefully placed slightly inside
the myocardium avoiding at the epicardial border to re-
duce a common tracking failure resulting from placing
the contours onto the boundary points of the pericar-
dium (Fig. 2). Similarly, when placing the endocardial
contours papillary muscles were avoided. When using
Medis, the delineation of endocardial contours in all
analysed sections was set at end systole, whereas epicar-
dial contours (as well as all end-diastolic contours) were
generated automatically. In most instances, the epicar-
dial required manipulation by the observer, similar to
the steps, described above. Care was taken to place the
epicardial contour slightly within the myocardium to
avoid tracking of the pericardium. Papillary muscles
were excluded when placing endocardial contour. After
completing the automated tracking process, the overall
quality of contour placement was re-evaluated by the re-
spective observer. Inadequate tracking, defined as appar-
ent deviations of the contours from the endocardial and
epicardial borders based on visual assessment, the con-
tours were manually corrected, and the automated algo-
rithm was reapplied (up to a maximum of 2 runs).
Segmental regions of interest (ROIs), which persistently
tracked poorly, were excluded from analysis. If persistent
poor tracking included more than two segments in a sin-
gle view, this patient’s case was excluded from the subse-
quent analysis.
Statistical analysis
Statistical analysis was performed using SPSS, version
24. Normality of distributions were tested using Shapiro-
Wilk test. Categorical data are expressed as counts (per-
centages), and continuous variables as mean ± SD or me-
dian (range), as appropriate. Mean difference (MD) ± SD
was calculated from each group substracting the mea-
sured values of two different observers divided by the
number of subjects measured in the respective group.
Comparisons between groups were performed using Stu-
dent t-test or one-way ANOVA for normally distributed
variables, and chi2 and Mann-Whitney test for non-
normally distributed variables. Fischer’s exact tests were
used to compare proportions. Inter- and intra-observer
variability was computed using the intra-class correlation
coefficients (ICC) using a two-way mixed model with ab-
solute agreement between measures and coefficient of
variance (CV) and the Bland-Altman plots. Effect size
between controls and patients based on GLS was
assessed Cohen’s D as well as using receiver operating
characteristic (ROC) curve analysis and calculation of
the area under the curve (AUC); AUCs pre and after
standardisation were compared using z-test statistics.
Cohen’s D were calculated comparing the mean GLS
values and the standard deviations pre- and poststandar-
dization with the respective control group. The AUCs
were calculated by integration of the graph produced by
Table 1 Subject characteristics
Variables Controls (n = 10) IHD (n = 15) DCM (n = 19)
Males (n, %) 7 (70) 10 (67) 9 (60)
Age (years) 34 ± 11 59 ± 14* 52 ± 18*
Heart rate (bpm) 62 ± 8 64 ± 11 62 ± 9
BP systolic (mmHg) 119 ± 9 136 ± 13 129 ± 21
BP diastolic (mmHg 69 ± 8 82 ± 9 79 ± 8
BMI kg/m2 27 ± 9 29 ± 11 28 ± 9
LV-EDV (index), ml/m2 79 ± 16 78 ± 14 101 ± 11*§
LV-ESV (index) ml/m2 34 ± 7 47 ± 12* 56 ± 14*§
LV-EF (%) 57 ± 2 40 ± 10* 43 ± 7*
LV mass (index), g/m2 54 ± 11 46 ± 10 78 ± 9*
LGE (n, %) / 15(100) 7 (47)
GLS (Medis) 20.12 ± 2.2 18.3 ± 2.2* 15.9 ± 2.4*§
GLS (CVI42) 23.51 ± 2.8 20.3 ± 3.9 16.8 ± 2.2
IHD Ischaemic heart disease, DCM Dilated cardiomyopathy, BMI Body mass
index, LV-EDV Left ventricular end-diastolic volume, LV-ESV End-systolic
volume, GLS Global longitudinal strain, one-way ANOVA, Bonferroni post-hoc
tests for the differences from control group, * - for the differences from
controls, § between the groups; p < 0.05 is considered significant
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Table 2 Results of pre and post-standardization analyses
All subjects Pre-Standardization Post-Standardization Sig. (p-value)
GLS Medis
Mean ± SD 16.9 ± 5.5 17.4 ± 2.7 0.32
IntraOB InterOB IntraOB InterOB
MD ± SD −0.3 ± 2.1 0.1 ± 1.1 0.23 ± 0.7 −0.51 ± 1.9
CV (%) 7.2 11 3.1 5.2
ICC 0.979 0.914 0.996 0.98
GLS CVI42
Mean ± SD 19.0 ± 4.5 19.0 ± 3.9 0.98
IntraOB InterOB IntraOB InterOB
MD ± SD −0.7 ± 2.3 −0.3 ± 1.3 − 0.2 ± 0.7 − 0.3 ± 1.1
CV (%) 4.6 4.7 4.3 4.4
ICC 0.978 0.964 0.995 0.993
Controls Pre-Standardization Post-Standardization Sig. (p-value)
GLS Medis
Mean ± SD 19.8 ± 5.3 20.71 ± 2.21 0.24
IntraOB InterOB IntraOB InterOB
MD ± SD −0.9 ± 3.5 −0.4 ± 2.6 0.5 ± 1.1 0.51 ± 1.1
CV (%) 3.8 6.5 2.2 2.2
ICC 0.88 0.85 0.96 0.92
GLS CVI42
Mean ± SD 24.1 ± 5.2 23.51 ± 2.8 0.58
IntraOB InterOB IntraOB InterOB
MD ± SD −0.7 ± 2.4 −0.6 ± 3.5 −0.7 ± 1.1 −1.2 ± 2.4
CV (%) 3.4 5.8 1.6 2.0
ICC 0.85 0.79 0.96 0.93
IHD Pre-Standardization Post-Standardization Sig. (p-value)
GLS Medis
Mean ± SD 16.2 ± 4.4 18.3 ± 2.2 0.45
Cohen D 0.74 1.09
IntraOB InterOB IntraOB InterOB
MD ± SD −0.4 ± 2.7 0.3 ± 1.9 0.3 ± 0.7 0.3 ± 0.8
CV (%) 6.8 7.6 2.3 3.2
ICC 0.79 0.81 0.92 0.89
GLS CVI42
Mean ± SD 19.4 ± 5.31 20.3 ± 3.9 0.63
Cohen D 0.89 0.95
IntraOB InterOB IntraOB InterOB
MD ± SD −0.8 ± 2.8 −0.5 ± 1.8 −0.4 ± 0.7 −0.5 ± 1.2
CV (%) 3.5 3.6 1.8 2.4
ICC 0.80 0.78 0.95 0.90
DCM Pre-Standardization Post-Standardization Sig. (p-value)
GLS Medis
Mean ± SD 16.38 ± 3.42 15.9 ± 2.4 0.599
Cohen D 0.77 2.09
IntraOB InterOB IntraOB InterOB
MD ± SD −0.2 ± 1.2 −0.9 ± 3.2 0.3 ± 0.7 −0.8 ± 0.6
CV (%) 6 3.5 2.3 1
ICC 0.74 0.79 0.93 0.96
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drawing the sensitivity of GLS on the y-axis and 1-
specificity on the x-axis in terms of discriminating be-
tween health and disease. All tests were two-tailed and
p-values <0.05 were considered statistically significant.
Results
Baseline characteristics are displayed in Table 1. The
final analysis included 44 subject cases: 15 patients with
IHD and regional wall motion abnormalities, 19 patients
with NIDCM and 10 healthy controls. Quantitative ana-
lysis was not diagnostic in 12 subjects, whereas in
17(39%) subjects 1 ROI had to be discarded. The results
of GLS measurements before and after standardization
are provided in Table 2 for both vendors. There were
significant differences between controls and all patients,
as well as patient subgroups, in most CMR measure-
ments, as well as GLS (p < 0.005) (summarised in Table
2); these differences were accentuated through
standardization procedures, as shown by significant in-
crease in Cohen D’s and AUCs (Fig. 3, Table 3). The
benefit of standardization was also evident through im-
proved CV and ICC agreements between observers and
the different vendors. Results of Bland Altman analyses
for inter-and intraobserver reproducibility for both ven-
dors prior to and after standardization are displayed in
Table 2 (plots Figs. 4, 5 and 6). Limits of agreement and
the coefficient of variation were reduced after
standardization within each vendor, albeit more strongly
for interobserver than intraobserver agreement (p = 0.03
vs <0.001, respectively) and more for MEDIS than
CVI42 (Medis: p < 0.000; CVI42: p < 0.028).
The common sources of poor reproducibility included:
 mis-selection of images (e.g. in case of repeated
acquisitions due to artefacts, poor breath-holding,
arrhythmia);
 the definition of end-diastole and end-systole (im-
proved by visual determination of frames with big-
gest/smallest volume and closed heart valves);
 the placement of endo- and epicardial contours by
 avoiding the dark pericardial rim or effusion
(poor tracking);
 exclusion of papillary muscles
 re-evaluation of sufficient tracking.
Mean GLS values for all subjects were on average 2
percentage points different between the two vendors
(p = 0.023), also on the subgroup level (p < 0.05), despite
relatively high agreement in overall measurements (r =
0.85, p < 0.001). Although the inter-vendor difference
persisted post-standardization, it was smaller compared
to initial results, substantiating the fixed element of sys-
tematic difference in derived measurements with two
vendors.
Discussion
Results of our study reveal that post-processing ap-
proach to GLS matters with respect to the reproducibil-
ity of measurements and detection of effective difference
in GLS between controls and patients. We demonstrate
that standardization of GLS post-processing helps to re-
duce the random component of variability, introduced
by inconsistencies between and within observers, while
fixed systematic inter-vendor bias due to vendor related
differences in image processing algorithms remained.
We further show that the greater precision of measure-
ments affords greater effect size, and as thus, improved
discrimination between controls and subgroups of pa-
tients, which was not vendor-dependent. Results of our
study provide a proof of concept that standardization of
GLS measurements is an essential step in ensuring the
reliable quantification of myocardial deformation, be-
tween different observers, users and across vendors.
Previous studies leading up to the present work have
highlighted the differing normal values as well as the re-
sults for intra- and interobserver reproducibility, as well
as between vendors and centres (summarised in Table
1S from PMID:19789193) [16]. In summary, the re-
ported intraobserver CV ranges between 5.2–12.3%,
whereas interobserver CV 10.9–15.4%, and our initial re-
sults agree well with these previous reports. However,
we have shown that by following the standardization
protocol considerably improves reproducibility of mea-
surements, in the study group as a whole, as well as sub-
groups. By employing a standardization protocol, CMR-
FT can become an objective and reproducible method
Table 2 Results of pre and post-standardization analyses (Continued)
GLS CVI42
Mean ± SD 17.7 ± 5.71 16.8 ± 2.2 0.26
Cohen D 1.17 2.67
IntraOB InterOB IntraOB InterOB
MD ± SD −0.6 ± 2.1 −0.3 ± 1.1 −0.5 ± 0.6 −0.4 ± 0.9
CV (%) 3.5 3.6 1.3 2.3
ICC 0.78 0.75 0.95 0.93
IHD Ischaemic heart disease, DCM Dilated cardiomyopathy, GLS Global longitudinal strain, MD Mean differences, SD Standard deviation, paired and unpaired t-test
for repeated measurements and the differences between the group, *p < 0.05 is considered significant
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for the quantification of LV deformation. Whereas the
burden of contour manipulation may at first appear sub-
stantial, we have narrowed this down to a few essential
and systematic steps, predictable of failure of tracking, as
well as vendor-specific contour placement, which has
proactively served to considerable improvement. This in-
formation is important as it may guide the necessary
optimization steps of CMR-FT softwares, in order to ad-
equately serve the clinical routine. Diversity of normal
values is often noted limitation of CMR-FT, yet the
range of the thus-far reported mean values is admittedly
narrow (19–21.3%, Table 1S), also reproduced by the re-
cent metanalysis by Vo et al., 20.1% [11]. Majority of the
previous studies used TomTec based software [6, 7], a
product using the same tracking algorithm as the
MEDIS software, and our MEDIS derived values in con-
trols reproduce these previous reports. The systematic-
ally higher measurements with CVI42 signal a very
different image-processing approach; yet the high inter-
vendor agreement of measurements suggests that al-
though the softwares may be employing different algo-
rithms, they track similar features of myocardial
deformation. The benefits of standardization can further
be seen through marked improvement of CV and ICC
and Bland Altman plots, reflecting the effect of
harmonization for both intra- and inter-observer vari-
ability. Reduction of the mean differences and limits of
agreement translate into smaller dispersion of the GLS
measurements, which is greater for interobserver repro-
ducibility. Applying the standardized steps improved re-
sults for both vendors; vendor-specific steps clearly
helped to reduce intervendor bias, again communicating
a random variability component or, in other words, the
many ways in which different observers could potentially
use the different softwares. Our findings emphasize the
role of clear and documented instructions and their un-
conditional implementation, in support of multi-user
transferability in routine clinical practice.
The detection of early disease relies on precision in
the technique, which can control for misclassification
from healthy subjects. The patients and groups in our
study were selected to be representative of the com-
mon clinical scenarios, where employment of GLS is
known to be complementary to the assessment of glo-
bal LV function, e.g. the mid-range LV-EF 30–50%
[17]. Compared to controls, both patient groups were
Fig. 3 ROC Curve analyses for discrimination between health vs disease
Table 3 Results of ROC analyses for separation between the
groups prior to and after standardization (AUC, 95%CI)
Tests AUC (95%CI)
Prestandardization Poststandardization
MEDIS
Controls vs All 0.909 (0.78–1.00) 0.976 (0.94–1.00)
Controls vs IHD 0.933 (0.82–1.00) 0.953 (0.88–1.00)
Controls vs DCM 0.89 (0.74–1.00) 0.985 (0.967–1.00)
CVI42
Controls vs All 0.903 (0.77–1.00) 0.988 (0.96–1.00)
Controls vs IHD 0.867 (0.71–1.00) 0.958 (0.89–1.00)
Controls vs DCM 0.932 (0.82–1.00) 0.988 (0.94–1.00)
IHD Ischaemic heart disease, DCM Dilated cardiomyopathy
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older and had significantly but similarly reduced glo-
bal systolic function. In both groups, GLS values were
significantly lower in comparison to controls. Of note,
comparative GLS measurements between IHD and
DCM group revealed significantly lower GLS in the
DCM group (p < 0.001). This is an important observa-
tion, which is in part explained by considerably
higher LV volumes in DCM group, indicating the
presence of global remodelling and consequently, op-
eration at much higher loading. In the IHD group,
Fig. 4 Results of reproducibility for intervendor agreement between Medis and CVI42. a – Bland Altman pre-standardization (Mean = 2.14; limits
of agreement: +1.96s = 9.21 -1.96s = -4.33), (b) - Bland Altman post-standardization (Mean = 1.54; limits of agreement: +1.96s = 5.76 -1.96s
= -2.69)
Fig. 5 Bland Altman plot for observer agreement Medis: a- pre-standardization intraobserver (Mean = -0.18; limits of agreement: +1.96s = 3.96
-1.96s = -4.32); b- post-standardization intraobserver (Mean = 0.23; limits of agreement: +1.96s = 1.44 -1.96s = -0.98); c -pre-standardization
interobserver (Mean = 0.29; limits of agreement: +1.96s = 7.84 -1.96s = -7.25); d- post-standardization interobserver (Mean = 0.33; limits of
agreement: +1.96s = 1.76 -1.96s = -1.10)
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GLS is reduced considerably, but only owing to severe
regional impairment, whereas the preserved myocar-
dium at first compensates with hypertrophic response
and not change of loading [1, 18]. Given the rather
homogenous presentation of cases within the model
disease groups, the AUC for separation of patient
groups from healthy controls were excellent before
and after standardization, although additional im-
provement remains notable.
The introduction of CMR-FT was long hailed as a
much-needed clinical application that reuses the rou-
tine cine acquisitions, while reducing the need for
additional imaging that encode the changes with myo-
cardial deformation, such as tagging. The overall via-
bility of this technology appeared to depend on the
availably of a quick, sleek and foremost accurate off-
line postprocessing, which resulted in offspring of
several dedicated software products for CMR-FT. Yet
the results of CMR-FT analyses vary from vendor to
vendor and remain highly observer dependent. Several
solutions were proposed, foremost the averaging of
results of repeated analyses for increasing intra-
vendor reproducibility [11]. Our results reveal that
benefit of such solution is likely dubious, the doub-
ling or tripling of analysis time notwithstanding, as
the source of high variability primarily arise from
the tracking failure of automatically detected (auto-)
contours, which cannot be improved by repetition,
but manipulation of contour placement on post-
processed SSFP images. In our study, this approach
turned out to influence most strongly the accuracy
of CMR-FT and several reasons underlie this obser-
vation. There are many independent variables that
cannot be improved by repetitive tracking including
image quality, frame rate, slice geometry (e.g. cutting
through the papillary muscles), observer and centre
experience. Image quality will suffer with poor
breath-capacity, mitral annular calcification, pericar-
dial effusion, mis-triggering, low frame rate and im-
perfect slice positioning, and will result in poor
auto-tracking due to difficult endo- and epicardial
border definition and misallocation of placed bound-
ary points. Institutional structures mandating stan-
dardised approaches and providing adequate training
will have high impact on reproducibility and
precision.
Fig. 6 Bland Altman plot for observer agreement CVI42. a pre-standardization intraobserver (Mean = -1.16; limits of agreement: +1.96s = 3.30
-1.96s = -5.63); b post-standardization intraobserver (Mean = -0.54; limits of agreement: +1.96s = 0.80 -1.96s = -1.89); c pre-standardization
interobserver (Mean = -0.57; limits of agreement: +1.96s = 2.05 -1.96s = -3.18); d post-standardization interobserver (Mean = -0.39; limits of
agreement: +1.96s = 1.83 -1.96s = -2.60)
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Conclusion
Standardization of GLS postprocessing helps to reduce
the random component of variability, introduced by in-
consistencies of and between observers, and to some ex-
tent also intervendor variability. There remains fixed
systematic inter-vendor bias due to vendor related differ-
ences in image processing algorithms. Greater precision
of measurements affords an improved effect size, and as
thus, discrimination between controls and subgroups of
patients, irrespective of the choice of postprocessing
software or underlying pathophysiology. Results of our
study provide a proof of concept that standardization of
GLS measurements is an essential step in ensuring the
reliable quantification of myocardial deformation, be-
tween different observers, users and across vendors, and
for implementation of CMR-FT in clinical routine.
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ventricle; NIDCM: Non-ischaemic dilated cardiomyopathy; ROC: Receiver
operated characteristic; ROI: Region of interest; RWMA: Regional wall motion
abnormalities; SAX: Short axis
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